Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BCPC - BALCHEM CORP


IEX Last Trade
164.71
-2.260   -1.372%

Share volume: 0
Last Updated: Fri 27 Dec 2024 03:30:00 PM CET

PREVIOUS CLOSE
CHG
CHG%

$166.97
-2.26
-1.35%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
1.11%
1 Month
-8.31%
3 Months
-4.58%
6 Months
10.69%
1 Year
12.76%
2 Year
37.25%
Key data
Stock price
$164.71
P/E Ratio 
55.95
DAY RANGE
N/A - N/A
EPS 
$3.59
52 WEEK RANGE
$138.38 - $186.03
52 WEEK CHANGE
$11.19
MARKET CAP 
6.534 B
YIELD 
0.78%
SHARES OUTSTANDING 
32.444 M
DIVIDEND
$0.3984
EX-DIVIDEND DATE
12/26/2023
NEXT EARNINGS DATE
10/25/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$209,936
AVERAGE 30 VOLUME 
$138,631
Company detail
CEO: Theodore L. Harris
Region: US
Website: balchem.com
Employees: 1,340
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Balchem Corporation develops, manufactures, and markets specialty performance ingredients for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets. It operates through three segments: Human Nutrition, Animal Nutrition & Health, and Specialty Products. The company sells its products through sales force, independent distributors, and sales agents.

Recent news